Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma

As the first oral multi-target anti-tumor drug proved for the treatment of patients with advanced liver cancer in 2007, sorafenib has changed the landscape of advanced hepatocellular carcinoma (HCC) treatment. However, drug resistance largely hinders its clinical application. Non-coding RNAs (ncRNAs...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Oncol
Autori principali: Lai, Yongting, Feng, Bing, Abudoureyimu, Mubalake, Zhi, Yingru, Zhou, Hao, Wang, Ting, Chu, Xiaoyuan, Chen, Ping, Wang, Rui
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2019
Soggetti:
Oncology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6848262/
https://ncbi.nlm.nih.gov/pubmed/31750247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.01156
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi